Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | AXSM | BMRN | ||
| Company | Acceleron Pharma | Axsome Thera | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.85 | 220.56 | 54.15 | ||
| High | 179.85 | 223.43 | 54.55 | ||
| Low | 177.06 | 216.77 | 53.53 | ||
| Latest | 178.75 | 217.38 | 54.06 | ||
| Change | -0.93 | -2.84 | -0.06 | ||
| % Change | -0.52% | -1.29% | -0.11% | ||
| Volume | 7,884,200 | 574,200 | 1,972,400 | ||
| 20-Day Average Volume | 1,302,050 | 912,580 | 1,754,015 | ||
| Previous Close | 179.68 | 220.22 | 54.12 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 196.21 | 54.30 | ||
| 20-Day Raw Stochastic | 84.01% | 71.26% | 32.20% | ||
| 20-Day Relative Strength | 70.12 | 69.63 | 45.84 | ||
| Weighted Alpha | +57.78 | +115.79 | -8.73 | ||
| Today's Opinion | 100% Buy | 100% Buy | 72% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 72% Sell | ||
| Last Month's Opinion | 88% Buy | 72% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | +5.25% since 05/01/26 | unch since 05/01/26 | ||
| Low | 173.17 on 11/16/21 | 208.50 on 05/04/26 | 52.65 on 05/05/26 | ||
| High | 179.94 on 11/17/21 | 234.29 on 05/04/26 | 57.44 on 05/05/26 | ||
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | +25.52% since 04/08/26 | -5.49% since 04/08/26 | ||
| Low | 172.25 on 10/20/21 | 172.02 on 04/09/26 | 52.46 on 04/29/26 | ||
| High | 179.94 on 11/17/21 | 234.29 on 05/04/26 | 57.44 on 05/05/26 | ||
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | +19.08% since 02/06/26 | -7.00% since 02/06/26 | ||
| Low | 120.20 on 08/20/21 | 152.28 on 03/24/26 | 52.46 on 04/29/26 | ||
| High | 189.99 on 09/29/21 | 234.29 on 05/04/26 | 66.28 on 02/24/26 | ||
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | +57.35% since 11/07/25 | +5.05% since 11/07/25 | ||
| Low | 113.49 on 07/15/21 | 136.00 on 11/14/25 | 50.90 on 12/15/25 | ||
| High | 189.99 on 09/29/21 | 234.29 on 05/04/26 | 66.28 on 02/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 11,186,374 | 10,448,933 | ||
| Shares Outstanding, K | 61,156 | 51,460 | 193,284 | ||
| Annual Sales | 92,520,000 | 638,500,000 | 3,221,250,000 | ||
| Annual Net Income | -166,030,000 | -183,170,000 | 348,900,000 | ||
| Last Quarter Sales | 34,200,000 | 196,000,000 | 874,560,000 | ||
| Last Quarter Net Income | -70,470,000 | -28,560,000 | -46,570,000 | ||
| 60-Month Beta | 0.13 | 0.59 | 0.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | -1.26 on 05/04/26 | 0.76 on 05/04/26 | ||
| Earnings Date | 02/24/22 | 08/03/26 | 08/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 26.66 | ||